[
THE INVESTOR] As of June 20 01:25 P.M., Daewoong Pharmaceutical declined 3.56%, compared with yesterday, to 86,600 won. It had declined 7.77% through the past month. Standard deviation, which indicates risk, records 2.3% over the same period over one month.
Compared with its close competitors within the same industry, KOSPI, as the monthly volatility of Daewoong Pharmaceutical had relatively expanded, the investment return for 1 month was negative. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -3.3%. As high volatility and a bearish stock price trend, the return-on-risk recorded a low value. Moreover, compared with the KOSPI industry, the return-on-risk is below the industrial mean, 7.2, and thus it is hard to say that the industrial comparison performance was positive.
By HeRo (
hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.